NIDO-361 clinical trials

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of NIDO-361 in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

This study is testing a new medicine, NIDO-361, for men with Spinal and Bulbar Muscular Atrophy (SBMA). Researchers want to see if it helps improve muscle size and strength, and if it's safe. Some men will get the medicine, others a dummy pill.